Results 101 to 110 of about 1,964 (176)

Long-Term Efficacy and Safety of Secukinumab in Children and Adolescents with Moderate-to-Severe Chronic Plaque Psoriasis: Four-Year Results of a Randomized, Phase III, Open-Label Trial. [PDF]

open access: yesPaediatr Drugs
Kingo K   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy